Listing 1 - 8 of 8 |
Sort by
|
Choose an application
Emerging from the protective environment of the uterus, the newborn is exposed to a myriad of microbes, and quickly establishes a complex microbiome that shapes the infant’s biology in ways that are only now beginning to come to light. Among these exposures are a number of potential pathogens. The host responses to these pathogens in the neonatal period are unique, reflecting a developing immune system even with delivery at term. Preterm infants are delivered at a time when host defense mechanisms are even less developed and therefore face additional risk. As such, the organisms that cause disease in this period are different from the pathogens that are common in other age groups, or the disease they cause manifests in more severe fashion. Developmental alterations in both innate and adaptive immune responses in neonates have been documented among many cell types and pathways over the last several decades. Contemporary insights into the human immune system and methodologies that allow an “omics” approach to these questions have continued to provide new information regarding the mechanisms that underlie the human neonate as an “immunocompromised host.” This Research Topic highlights studies related to this unique host-pathogen interface. Contributions include those related to the innate or adaptive immune system of neonates, their response to microbial colonization or infection, and/or the pathogenesis of microbes causing disease in neonates.
Infection --- Neonate --- Candida --- Sepsis --- Necrotizing enterocolitis --- Vaccine --- Immunity --- Microbiome
Choose an application
Studies focusing on the perinatal period face unique challenges, yet research in this area is extremely important, as this period of life is highly delicate and adverse events might have a long-lasting impact. With the advent of powerful high-resolution and high-throughput analytical methods, researchers have started to successfully develop and implement novel approaches in this area. New insights have great potential to be translated into novel diagnostic tools, as well as alternative preventive and treatment approaches. This book collects a series of timely review and original research articles focusing on metabolomic, oxidative, and nitrosative stress in the perinatal period.We would like to thank all involved authors for their high-quality contributions and their commitment to the publication of this work and hope that this book will be a useful resource for students, scientists, and doctors working in this specific area of application.
glutathione --- glutamate --- oxidative stress --- hypoxia ischemia --- endotoxin --- magnetic resonance spectroscopy --- N-acetylcysteine --- vitamin D --- neonatal HIE --- MRS --- preterm birth --- sex differences --- male disadvantage --- female advantage --- bronchopulmonary dysplasia --- retinopathy of prematurity --- necrotizing enterocolitis --- intraventricular hemorrhage --- periventricular leukomalacia --- mortality --- transposition of the great arteries --- balloon atrial septostomy --- hypoxemia --- metabolomics --- newborn --- liquid chromatography-mass spectrometry (LC-MS) --- allopurinol --- hypothermia --- hypoxic-ischemic encephalopathy --- oxidative damage --- donor milk --- treatment --- Holder pasteurization --- breastmilk --- preterm --- antioxidant capacity --- asphyxia neonatorum --- non-invasive diagnostics --- saliva --- neonatal hypoxia–ischemia --- kynurenic acid (KYNA) --- neuroprotection --- hyperoxia --- prematurity --- n/a --- neonatal hypoxia-ischemia
Choose an application
This Nutrients Special Issue focuses on neonatal nutritional advances for inflammatory disorders affecting infants such as necrotizing enterocolitis (NEC). Nutrition can significantly impact the development of certain diseases that afflict infants. This Special Issue aims to bring together the latest research on the role of nutrition in preventing or impacting neonatal disorders. Specifically, this Special Issue focuses on the role of breast milk or donor breast milk and the various components in milk that have been demonstrated to protect against NEC and other inflammatory diseases. This issue provides a comprehensive composite of the advances in nutritional strategies that can modulate or prevent neonatal intestinal disorders.
donor breast milk --- human milk --- milk analysis --- very low birth weight --- preterm --- growth --- preterm infant --- donor human milk --- formula feeding --- breastfeeding --- necrotizing enterocolitis --- breast milk --- prematurity --- immunity --- newborn --- inflammation --- colostrum administration --- premature neonates --- clinical outcomes --- intestinal resection --- short bowel syndrome --- intestinal adaptation --- microbiome --- parenteral nutrition --- hormones --- milk fat globule --- long chain polyunsaturated fatty acids --- premature infants --- neonatal --- intestine --- glycosaminoglycans --- intestinal inflammation --- bioactive --- donor milk --- gastroschisis --- intestinal atresia --- human milk fortifier --- patient empowerment --- neonatal nutrition --- communication --- product labeling --- NICU parent --- extracellular vesicle --- exosome --- immature intestine --- formula --- osmolality --- breastmilk --- late onset sepsis --- bloodstream infections --- enteric pathogens --- human milk banks --- NEC --- meta-analysis --- breast-feeding --- spontaneous intestinal perforation --- feeding --- nutrition
Choose an application
This book represents a collection of paper from different specialists involved in the management of septic patients, aimed to disseminate the knowledge in the field of sepsis, particularly to non-intensivists physicians.
internal medicine --- intensive care --- emergency department --- organ dysfunction --- immunomodulation --- micronutrients --- antimicrobial stewardship --- shock septic --- antioxidant therapy --- oxidative stress --- multiple organ failure --- procalcitonin --- qSOFA --- sepsis --- fever --- procalcitonin kinetics --- prognostication --- sepsis biomarkers --- vitamin D --- vitamin C --- zinc --- thiamine --- nutrition --- critically ill patients --- infections --- mitochondria --- shock --- multidrug-resistant bacteria --- Klebsiella NDM --- ceftazidime-avibactam --- septic shock --- infection --- extracorporeal immune modulation --- blood purification --- renal replacement therapy --- afebrile patients --- neutropenic enterocolitis --- chemotherapy-induced damage --- antifungal stewardship --- Candida bloodstream infection --- echinocandin --- Presepsin --- critical care --- ICU --- neutrophil-to-lymphocyte --- platelet-to-lymphocyte --- C-reactive protein --- MRproAdrenomedullin --- systemic inflammatory response syndrome --- sequential organ failure assessment --- quick-sequential organ failure assessment --- proadrenomedullin --- MR-proADM --- n/a
Choose an application
The goal of this Special Issue, “Probiotics and Prebiotics in Pediatrics”, is to focus on the importance of pediatric nutrition with probiotics and prebiotics to improve gastrointestinal health in newborn, infants, and children.Specifically, the aim is to clarify if probiotics and prebiotics can influence gut microbiota composition and host-interaction favoring human health and preventing diseases.This new information will provide health care professionals with a widespread, clear and update evidence on probiotics and prebiotics and intestinal gut microbiota in pediatric care.
non-IgE mediated allergy --- n/a --- randomized controlled trials --- infant --- “Probiotics”[Mesh] --- children --- safety --- therapeutic microbiology --- zinc --- prevention --- Lactobacillus --- cow’s milk protein --- constipation --- hepcidin --- infants --- Bifidobacterium --- Bifidobacterium breve --- allergy --- asthma --- functional abdominal pain disorders --- probiotic strain --- formula feeding --- probiotic --- nutritional programming --- 2?-fucosyllactose --- “Pregnancy”[Mesh] --- colic --- iron absorption --- bifidobacteria --- Newborn”[Mesh] --- breast feeding --- neonatal --- diversity --- acute diarrhea --- celiac disease --- human milk oligosaccharide --- acute gastroenteritis --- human milk oligosaccharides --- tolerance acquisition --- iron deficiency anemia --- infantile colic --- Lacto-N-neotetraose --- gluten free diet --- oligosaccharides --- preterm --- preterm infant --- microbial programming --- paediatrics --- Lactobacillus reuteri --- functional constipation --- protein hydrolyzed formulas --- oral rehydration solution --- gluten-free diet --- infant formula --- prebiotic --- Childhood Asthma Control Test --- microbiome --- intestinal transit time --- prebiotics --- sepsis --- probiotics --- microbiota --- “Infant --- lactobacilli --- human milk --- functional gastrointestinal disorders --- inulin --- fecal microbiota --- Bacillus clausii --- peak expiratory flow rate --- breast milk --- immunoglobulin E --- efficacy --- intestinal microbiota --- necrotizing enterocolitis --- pediatrics --- growth --- "Probiotics"[Mesh] --- cow's milk protein --- "Pregnancy"[Mesh] --- Newborn"[Mesh] --- "Infant
Choose an application
The plant-derived polyphenol curcumin has been used in promoting health and combating disease for thousands of years. Its therapeutic effects have been successfully utilized in Ayurvedic and Traditional Chinese Medicine in order to treat inflammatory diseases. Current results from modern biomolecular research reveal the modulatory effects of curcumin on a variety of signal transduction pathways associated with inflammation and cancer. In this context, curcumin’s antioxidant, anti-inflammatory, anti-tumorigenic, and even anti-metastatic activities are discussed. On the cellular level, the reduced activity of several transcription factors (such as NFkB or AP-1) and the suppression of inflammatory cytokines, matrix degrading enzymes, metastasis related genes and even microRNAs are reported. On functional levels, these molecular effects translate into reduced proliferative, invasive, and metastatic capacity, as well as induced tumor cell apoptosis. All these effects have been observed not only in vitro but also in animal models. In combination with anti-neoplastic drugs like Taxol, kinase inhibitors, and radiation therapy, curcumin potentiates the drugs’ therapeutic power and can protect against undesired side effects. Natural plant-derived compounds like curcumin have one significant advantage: They do not usually cause side effects. This feature qualifies curcumin for primary prevention in healthy persons with a predisposition to cancer, arteriosclerosis, or chronic inflammatory diseases. Nonetheless, curcumin is considered safe, although potential toxic effects stemming from high dosages, long-term intake, and pharmacological interactions with other compounds have yet to be assessed. This Special Issue examines in detail and updates current research on the molecular targets, protective effects, and modes of action of natural plant-derived compounds and their roles in the prevention and treatment of human diseases.
minerals --- cancer treatment --- chitosan --- n/a --- neurodegeneration --- antioxidant activity --- senescence --- tumor proliferation --- nanoparticles --- antimicrobial agents --- oxidative metabolites --- drug discovery --- Akt/mTOR signaling --- micronutrients --- ulcerative colitis --- transmission electron microscopy --- metabolic reprogramming --- curcumin --- death receptor --- chaperone-mediated autophagy --- wound healing --- brain ischemia --- autophagy --- Alzheimer’s disease --- genes --- transthyretin --- inflammatory bowel disease --- cellular pathway --- centrifugal partition chromatography --- nutrition --- amyloid --- Curcuma longa --- protein aggregation --- supportive care --- IL-17 --- senolytics --- complementary medicine --- macronutrients --- structure activity relationship --- gastroprotection --- Zingiberaceae --- anti-inflamation --- TLC bioautography --- microbiota --- glioblastoma multiforme --- amyloidosis --- SHMT2 --- antioxidants --- silica --- apoptosis --- reflux esophagitis --- gastric ulcer --- TLC-MS --- anti-cancer --- anticancer --- ImageJ --- anti-tumor --- delivery system --- wound --- Helicobacter pylori --- direct protein binding --- protein misfolding --- tumor growth --- diet --- Crohn’s disease --- hydrostatic counter-current chromatography --- ageing --- renal cell cancer --- gastric cancer --- amino-acids --- STAT3 --- mechanism of action --- inflamm-aging --- mitophagy --- necrotizing enterocolitis --- cell cycling --- vitamins --- turmeric tuber --- cancer --- tau protein --- Alzheimer's disease --- Crohn's disease
Choose an application
This Special Issue of Nutrients is addressing the topic ‘Nutrition, Diet and Food Allergy’. Globally, food allergy affects 1.5% of adults and 5% of children and this prevalence is increasing in recent decades, representing a public health problem. Different mechanisms are involved in food allergic diseases with distinctive clinical characteristics: IgE-mediated and non-IgE-mediated phenotypes will be distinguished in the Issue, considering the early recent literature on the prevalence, age of onset, follow-up recommendations and duration of food allergies. Moreover, the management of these fascinating diseases will be discussed with particular attention on nutritional hazards, risks of allergic reactions to new allergens, problems with missed labelling (precautionary allergen labelling (PAL)). Especially, the dietary restrictions and the re-introduction of allergens lead to a significant burden for affected patients, fear of accidental ingestions and related risk of severe reactions, resulting in a reduced quality of life among patients with food allergies.
Medicine --- nutrients --- infant gut microbiome --- pregnancy --- vegetables --- fruits --- atopic dermatitis --- dysbiosis --- food allergy --- gut --- infants --- microbiota --- skin --- 16S rRNA sequencing --- allergy --- anemia --- cow’s milk --- children --- immunology --- non-IgE-mediated food allergy --- pneumonia --- pulmonary hemosiderosis --- pulmonary infiltrates --- nut allergy --- oral food challenge --- peanut --- prick by prick --- serum specific IgE --- skin prick test --- tree nut --- milk allergy --- non-IgE mediated CMA --- food protein-induced enterocolitis syndrome --- FPIES --- labelling --- prevention --- proteomics --- mass spectrometry --- cow’s milk allergy --- food hypersensitivity --- gastrointestinal disorder --- non-IgE-mediated food hypersensitivity disorder --- wheat allergy --- anaphylaxis --- epinephrine --- schools --- scoping review --- teachers --- peach allergy --- molecular allergy --- Pru p 3 --- Pru p 7 --- peamaclein --- oral allergy syndrome --- pollen-food allergy syndrome --- oral immunotherapy --- undeclared allergens --- pediatric --- food allergies --- risk --- RASFF
Choose an application
We have entered a new era where some concepts of the complex community of microorganisms (microbiota comprising bacteria, fungi, viruses, bacteriophages and helminths) are being re-discovered and re-visited. Microbiota and human interaction is not new; they have shared a long history of co-existence. Nevertheless, the opportunities to understand the role of these microorganisms in human diseases and to design a potential treatment were limited. At present, thanks to development of innovative and cutting-edge molecular biological and microbiological technologies as well as clinical informatics and bioinformatics skills, microbiome application is moving into clinics. Approaches to therapy based on prebiotics, probiotics and lately on fecal microbiota transplantation has revolutionized medicine. Microbiota outnumbers our genes and is now regarded as another organ of the body. The gastrointestinal tract and gut microbiota display a well-documented symbiotic relationship. Disruption of intestinal microbiota homeostasis—called dysbiosis—has been associated with several diseases. Whether dysbiosis is a cause or consequence of disease initiation and progression still needs to be investigated in more depth. The aim of this book is to highlight recent advances in the field of microbiome research, which are now shaping medicine, and current approaches to microbiome-oriented therapy for gastrointestinal diseases. Dr. Rinaldo Pellicano Dr. Sharmila Fagoonee Guest Editors
Bacteroides ovatus --- Bifidobacterium adolescentis --- Dysbiosis --- Faecalibacterium prausnitzii --- Ruminococcus gnavus --- type 1 diabetes --- microbiota --- microbiome --- auto-immunity --- gut permeability --- gut --- IBS --- celiac disease --- enteropathy --- gluten --- therapy --- gut microbiota --- precision medicine --- Clostridium difficile --- inflammatory bowel disease --- ulcerative colitis --- irritable bowel disease --- metabolic syndrome --- gastric microbiota --- transient --- persistent --- culture --- sequencing --- Helicobacter pylori --- fecal microbiota transplantation --- feces donor --- fecal microbiota --- flow cytometry --- viability of bacteria --- next-generation sequencing --- culturing of fecal microbiota --- Alzheimer’s disease --- microbiota–gut–brain axis --- neurodegenerative disease --- intestinal flora --- necrotizing enterocolitis --- intestinal microbiology --- infant gut --- metabolomics --- IL-6 --- IL-8 --- IL-12p70 --- intestinal permeability --- zonulin --- gut virome --- steatosis --- cirrhosis --- hepatocellular carcinoma --- gastrointestinal --- technology --- high-throughput --- crohn’s disease --- mononuclear cells --- transient receptor potential channel --- pancreatic diseases --- acute pancreatitis --- chronic pancreatitis --- diabetes mellitus --- pancreatic ductal adenocarcinoma --- pancreatic cystic neoplasms
Listing 1 - 8 of 8 |
Sort by
|